Due to safety considerations, the replication of oncolytic Ad vectors, in general, is usually restricted to cancer cells, either by using tissue-/tumor-specific promoters to control E1A expression, or by introducing mutations into E1A and/or E1B, the latter in principle disabling viral replication in non-neoplastic cell types. The gene discussed is DHTKD1; the disease is neoplasm.